Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:
Beijing Shougang Gas Company Limited